Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Case 31-2017: A 19-Month-Old Girl with Failure to Thrive.

Malozowski S.

N Engl J Med. 2018 Feb 15;378(7):685. doi: 10.1056/NEJMc1714806. No abstract available.

PMID:
29489302
2.

Glucocorticoid use and its association with skeletal health among U.S. adults with diabetes.

Casagrande SS, Cowie CC, Malozowski S.

J Diabetes Complications. 2017 Feb;31(2):353-357. doi: 10.1016/j.jdiacomp.2016.06.021. Epub 2016 Jun 27.

3.

Severe hypoglycemia symptoms, antecedent behaviors, immediate consequences and association with glycemia medication usage: Secondary analysis of the ACCORD clinical trial data.

Bonds DE, Miller ME, Dudl J, Feinglos M, Ismail-Beigi F, Malozowski S, Seaquist E, Simmons DL, Sood A.

BMC Endocr Disord. 2012 May 30;12:5. doi: 10.1186/1472-6823-12-5.

4.

Reports of increased mortality and GH: will this affect current clinical practice?

Malozowski S.

J Clin Endocrinol Metab. 2012 Feb;97(2):380-3. doi: 10.1210/jc.2011-3363. No abstract available.

5.

Biosimilars.

Malozowski S.

Arq Bras Endocrinol Metabol. 2011 Nov;55(8):669.

6.

Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline.

Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Vance ML; Endocrine Society.

J Clin Endocrinol Metab. 2011 Jun;96(6):1587-609. doi: 10.1210/jc.2011-0179.

PMID:
21602453
7.

Propylthiouracil-induced hepatotoxicity and death. Hopefully, never more.

Malozowski S, Chiesa A.

J Clin Endocrinol Metab. 2010 Jul;95(7):3161-3. doi: 10.1210/jc.2010-1141. No abstract available.

8.

Lasofoxifene for postmenopausal women with osteoporosis.

Malozowski S.

N Engl J Med. 2010 Jun 10;362(23):2227; author reply 2228-9. doi: 10.1056/NEJMc1003454. No abstract available.

PMID:
20558377
9.

Reevaluating erythropoiesis-stimulating agents.

Kimmel PL, Malozowski S.

N Engl J Med. 2010 May 6;362(18):1742-3; author reply 1743-4. No abstract available.

PMID:
20449880
10.

Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial.

Riddle MC, Ambrosius WT, Brillon DJ, Buse JB, Byington RP, Cohen RM, Goff DC Jr, Malozowski S, Margolis KL, Probstfield JL, Schnall A, Seaquist ER; Action to Control Cardiovascular Risk in Diabetes Investigators.

Diabetes Care. 2010 May;33(5):983-90. doi: 10.2337/dc09-1278.

11.

Abnormal responses to TRH in children born small for gestational age that failed to catch up.

Keselman A, Chiesa A, Malozowski S, Vieytes A, Heinrich JJ, de Papendieck LG.

Horm Res. 2009;72(3):167-71. doi: 10.1159/000232492. Epub 2009 Sep 1.

PMID:
19729948
12.

Klinefelter syndrome and cryptorchidism.

Gottlieb S, Rey RA, Malozowski S.

JAMA. 2009 Apr 8;301(14):1436-7; author reply 1437. doi: 10.1001/jama.2009.443. No abstract available.

PMID:
19351939
13.

Assessment of the long-term safety of inhaled ciclesonide on growth in children with asthma.

Malozowski S.

Pediatrics. 2008 Jul;122(1):213; author reply 213. doi: 10.1542/peds.2008-0037. No abstract available.

PMID:
18596012
14.

More on ovarian insufficiency with imatinib.

Malozowski S, Nelson L, Calis KA.

N Engl J Med. 2008 Jun 12;358(24):2648; author reply 2648-9. doi: 10.1056/NEJMc080707. No abstract available.

PMID:
18550885
15.

Comparative efficacy: what we know, what we need to know, and how we can get there.

Malozowski S.

Ann Intern Med. 2008 May 6;148(9):702-3. No abstract available.

PMID:
18458283
16.

Interleukin-1-receptor antagonist in type 2 diabetes mellitus.

Malozowski S, Sahlroot JT.

N Engl J Med. 2007 Jul 19;357(3):302-3; author reply 303. No abstract available.

PMID:
17634469
17.

Exenatide in combination therapy: small study, big market, and many unanswered questions.

Malozowski S.

Ann Intern Med. 2007 Apr 3;146(7):527-8. No abstract available.

PMID:
17404355
18.

Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society Clinical Practice Guideline.

Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Shalet SM, Vance ML; Endocrine Society's Clinical Guidelines Subcommittee, Stephens PA.

J Clin Endocrinol Metab. 2006 May;91(5):1621-34. Epub 2006 Apr 24. Review.

PMID:
16636129
19.

Treatment of adolescents with gynecomastia.

Malozowski S.

J Pediatr. 2005 Apr;146(4):576; author reply 576-7. No abstract available.

PMID:
15812473
20.

An update on type 2 diabetes in youth from the National Diabetes Education Program.

Bobo N, Evert A, Gallivan J, Imperatore G, Kelly J, Linder B, Lorenz R, Malozowski S, Marschilok C, Minners R, Moore K, Perez Comas A, Satterfield D, Silverstein J, Vaughn GG, Warren-Boulton E; Diabetes in Children Adolescents Work Group of the National Diabetes Education Program.

Pediatrics. 2004 Jul;114(1):259-63. Review. No abstract available.

PMID:
15231940
21.

Pancreatitis associated with atypical antipsychotics: from the Food and Drug Administration's MedWatch surveillance system and published reports.

Koller EA, Cross JT, Doraiswamy PM, Malozowski SN.

Pharmacotherapy. 2003 Sep;23(9):1123-30. Review.

PMID:
14524644
22.

Considerations for diabetes translational research in real-world settings.

Garfield SA, Malozowski S, Chin MH, Narayan KM, Glasgow RE, Green LW, Hiss RG, Krumholz HM; Diabetes Mellitus Interagency Coordinating Committee (DIMCC) Translation Conference Working Group.

Diabetes Care. 2003 Sep;26(9):2670-4. Review. No abstract available.

PMID:
12941736
23.

Use of growth hormone in elderly individuals.

Malozowski S.

JAMA. 2003 Jul 23;290(4):462. No abstract available.

PMID:
12876088
24.

Sildenafil and physical exertion in men with coronary artery disease.

Malozowski S, Sahlroot JT.

JAMA. 2002 May 8;287(18):2359; author reply 2359-60. No abstract available.

PMID:
12001945
25.

Atypical antipsychotic drugs and hyperglycemia in adolescents.

Koller E, Malozowski S, Doraiswamy PM.

JAMA. 2001 Nov 28;286(20):2547-8. No abstract available.

PMID:
11722267
26.

Role of hormones in puberty.

Malozowski S.

Lancet. 2001 Oct 27;358(9291):1459; author reply 1460. No abstract available.

PMID:
11705528
27.

The FDA and The Lancet: an exchange.

Malozowski S.

Lancet. 2001 Aug 4;358(9279):416-7; author reply 417-8. No abstract available.

PMID:
11503620
28.

Deception in bronchodilator inhaler use.

Koller E, Malozowski S, Johnson S.

Chest. 2001 Apr;119(4):1291-2. No abstract available.

PMID:
11296210
29.

Compliance with bronchodilator treatment.

Malozowski S, Koller E.

Chest. 2001 Mar;119(3):988-9. No abstract available.

PMID:
11243997
30.

Asthma, corticosteroids, and growth.

Purucker M, Malozowski S.

N Engl J Med. 2001 Feb 22;344(8):607; author reply 607-8. No abstract available.

PMID:
11221624
31.

Hemodynamic effects of sildenafil.

Malozowski S, Sahlroot JT.

N Engl J Med. 2000 Sep 28;343(13):967-8. No abstract available.

PMID:
11012322
32.

Aseptic necrosis in HIV seropositive patients: a possible etiologic role for megestrol acetate.

Koller E, Mann M, Malozowski S, Bacsanyi J, Gibert C.

AIDS Patient Care STDS. 2000 Aug;14(8):405-10.

PMID:
10977969
33.

Inhaled corticosteroids and bone density.

Purucker M, Malozowski S.

Lancet. 2000 Jul 29;356(9227):427. No abstract available.

PMID:
10972393
34.

Full remission of growth hormone (GH)-induced retinopathy after GH treatment discontinuation: long-term follow-up.

Hansen R, Koller EA, Malozowski S.

J Clin Endocrinol Metab. 2000 Jul;85(7):2627. No abstract available.

PMID:
10902819
35.

In vitro and in vivo responses to short-term recombinant human insulin-like growth factor-1 (IGF-I) in a severely growth-retarded girl with ring chromosome 15 and deletion of a single allele for the type 1 IGF receptor gene.

de Lacerda L, Carvalho JA, Stannard B, Werner H, Boguszewski MC, Sandrini R, Malozowski SN, Leroith D, Underwood LE.

Clin Endocrinol (Oxf). 1999 Nov;51(5):541-50.

PMID:
10594514
36.

Safety and regulatory issues in anabolic agents' use and development.

Malozowski S, Koller E.

JPEN J Parenter Enteral Nutr. 1999 Nov-Dec;23(6 Suppl):S214-5. No abstract available.

PMID:
10571458
37.

Inhaled corticosteroids and growth velocity in children with asthma.

Purucker M, Malozowski S.

J Pediatr. 1999 Aug;135(2 Pt 1):264-6. No abstract available.

PMID:
10431250
38.

Cushing's syndrome induced by betamethasone nose drops. Children taking intranasal corticosteroids should be monitored for growth retardation.

Malozowski S, Purucker M, Worobec A.

BMJ. 1999 May 15;318(7194):1355. No abstract available.

PMID:
10383213
39.

Comparison of beclomethasone, salmeterol, and placebo in children with asthma.

Malozowski S, Stadel BV, Pian LP.

N Engl J Med. 1998 Sep 3;339(10):704-5. No abstract available.

PMID:
9729145
40.

Retinal changes mimicking diabetic retinopathy in two nondiabetic, growth hormone-treated patients.

Koller EA, Green L, Gertner JM, Bost M, Malozowski SN.

J Clin Endocrinol Metab. 1998 Jul;83(7):2380-3.

PMID:
9661613
41.

Glucocorticoidlike activity of megestrol. A summary of Food and Drug Administration experience and a review of the literature.

Mann M, Koller E, Murgo A, Malozowski S, Bacsanyi J, Leinung M.

Arch Intern Med. 1997 Aug 11-25;157(15):1651-6. Review.

PMID:
9250225
42.

Papilledema in 15 renally compromised patients treated with growth hormone.

Koller EA, Stadel BV, Malozowski SN.

Pediatr Nephrol. 1997 Aug;11(4):451-4.

PMID:
9260244
43.

Benign intracranial hypertension in children with growth hormone deficiency treated with growth hormone.

Malozowski S, Tanner LA, Wysowski DK, Fleming GA, Stadel BV.

J Pediatr. 1995 Jun;126(6):996-9.

PMID:
7776116
44.

Growth hormone (GH) modulates insulin-like growth factor I (IGF-I) and type I IGF receptor mRNA levels in the ovary of prepubertal GH-deficient rats.

Malozowski S, Parmer TG, Trojan S, Merriam GR, Gibori G, Roberts CT Jr, LeRoith D, Werner H, Zilberstein M.

Eur J Endocrinol. 1995 Apr;132(4):497-501.

PMID:
7711889
45.

Prepubertal gynecomastia during growth hormone therapy.

Malozowski S, Stadel BV.

J Pediatr. 1995 Apr;126(4):659-61. Erratum in: J Pediatr 1995 Jul;127(1):159.

PMID:
7699552
46.

Acute pancreatitis associated with growth hormone therapy for short stature.

Malozowski S, Hung W, Scott DC, Stadel BV.

N Engl J Med. 1995 Feb 9;332(6):401-2. No abstract available.

PMID:
7824013
47.

Risks and benefits of insulin-like growth factor.

Malozowski S, Stadel B.

Ann Intern Med. 1994 Oct 1;121(7):549. No abstract available.

PMID:
8067657
48.

Induction of reversible growth retardation and growth hormone deficiency by blockade of norepinephrine synthesis in the rat.

Malozowski S, Mamalaki E, Pleti M, Armando I, Goldstein D, Merriam GR.

Acta Endocrinol (Copenh). 1993 Dec;129(6):554-8.

PMID:
7906468
49.

Endocrine profile of catch-up growth in the cynomolgus monkey.

Marin G, Malozowski SN, Barnes K, Southers J, Cristiano A, Cassorla F.

Acta Endocrinol (Copenh). 1993 Oct;129(4):371-4.

PMID:
8237258
50.

Growth hormone, insulin-like growth factor I, and benign intracranial hypertension.

Malozowski S, Tanner LA, Wysowski D, Fleming GA.

N Engl J Med. 1993 Aug 26;329(9):665-6. No abstract available.

PMID:
8341354

Supplemental Content

Loading ...
Support Center